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Peter Neglén, MD, PhD,a Rikki Darcey, BS,a Jake Olivier, PhD,b and Seshadri Raju, MD,a Flowood, Miss;
and Sydney, New South Wales, Australia
Objective: This study describes three techniques of stent placement at the iliocaval confluence for chronic nonmalignant
obstruction and its stent-related outcome.
Methods: From 1997 to 2008, 115 patients (230 limbs) underwent bilateral stenting for iliocaval obstruction. All limbs
were CEAP classified using clinical examination and duplex ultrasound study. Three techniques were compared:
placement of two stents side by side in a “double-barrel” (group DB, n  39); inverted Y stenting through a fenestra
(window) created through the side braiding of a stent placed previously across the iliocaval confluence (group iY, n 38);
apposition of a stent as close as possible to a stent previously placed across the iliocaval confluence, leaving a small area
unsupported between the stents (group A, n  38). Patency was assessed with venography and duplex ultrasound
imaging. Cumulative patency curves were calculated.
Result: Median age was 54 years (range, 14-76 years); female/male ratio was 2.8:1. Obstructions were primary in 141
limbs and postthrombotic in 89, and 29 required recanalization of occlusions. The C4-6 rate and ratio of limbs with
postthrombotic obstruction were significantly higher in group iY vs group DB (49% and 32% [P  .049]; 47% and 28%
[P .022], respectively). The median follow-up was 12 months (range, 1-108 months) in 107 patients (93%). The overall
primary, assisted primary, and secondary patency rates at 4 years were 61%, 92%, and 98%, respectively. The distribution
of occluded stent systems (n  4) and frequency of reinterventions (n  29) were reflected in the primary and secondary
patency rates for groups A, DB, and iY at 4 years (77% and 100%, 73% and 100%, and 41% and 90%, respectively). The
frequency of reinterventions was significantly lower in group DB vs groups A and iY (8%, 32%, and 37%, respectively;P< .01).
Conclusion: Chronic iliocaval confluence obstruction is best managed by double-barrel stenting when feasible. The
apposition technique requires a high reintervention rate owing to restenosis of the unsupported segment. The secondary
stent patency appears to be less in limbs with postthrombotic occlusion. Primary stent patency of nonocclusive
obstruction was inferior in group iY regardless of etiology of obstruction. However, inverted Y fenestration is the only
choice in delayed contralateral stenting or when the inferior vena cava is extensively involved. There is no optimal solution
to the treatment of the iliocaval confluence presently, and the choice of technique is decided by the extent, site, and type
of obstruction. (J Vasc Surg 2010;51:1457-66.)Percutaneous stenting of the femoroiliocaval venous
outflow, guided by intravascular ultrasound (IVUS) imag-
ing, is presently the method of choice in the treatment of
chronic venous obstruction. It is also the initial treatment in
patients with combined obstruction and reflux disease.1
Although the stent placement appears to be rather simple
technically, attention to details is vital to achieve an optimal
result. The endovenous procedure is minimally invasive,
with low morbidity, long-term stent patency, a low rate of
in-stent stenosis, and limited need for reinterventions. It
results in sustained relief of limb symptoms, a high rate of
healing of venous leg ulcers, in substantial improvement of
quality of life, and in decreased disability.2-6
Most commonly, the obstructive disease is unilateral.
In most of these limbs, an extension of the stenting into the
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doi:10.1016/j.jvs.2010.01.056inferior vena cava (IVC) is required when treating a focal
obstruction adjacent to the confluence of the common iliac
vein to avoid caudad migration and early recurrence of the
stenosis.7 Although the contralateral venous outflow is
crossed, it does not appear to significantly impair the flow
from the contralateral limbs so that thrombosis results.5
There is presently no dedicated stent available to avoid this
“jailing” of the contralateral outflow.
Bilateral iliac stenting with extension into the IVC is
necessary when the iliocaval confluence is primarily in-
volved or an obstruction of the contralateral iliac vein
develops after previous iliac vein stent placement. This
study describes different techniques of stent placement at
the iliocaval confluence for chronic nonmalignant obstruc-
tion and its stent-related outcome.
MATERIALS AND METHODS
A review of a venous stent database of 1607 limbs with
information collected prospectively from 1997 to 2008
revealed 115 patients (230 limbs) who underwent bilateral
stenting for occlusive or nonocclusive obstruction involv-
ing the iliocaval confluence. Primary lesions, so-called non-
thrombotic iliac vein lesions (NIVL), are caused by focal
nonocclusive external compression at arterial vessel cross-
ings or by the inguinal ligament, or both, sometimes com-
bined with intraluminal lesions such as webs and septa.1
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when:
● the patient had a known occurrence of deep vein
thrombosis diagnosed with duplex US (DUS) imaging
or ascending venogram and had subsequently been
treated by anticoagulation; or
● findings on venogram (occlusion, stenosis or collater-
als) or DUS imaging, or both, indicated previous deep
vein thrombosis below the inguinal ligament noted by
direct visualization of thrombus or indirect indication
by partial or total inability to compress the vein. The
different lesions have distinctive features on IVUS
imaging.1
No patient had acute deep vein thrombosis, and none
was treated by thrombolysis before stenting. The median
duration of symptoms was 12 months (range, 2-360
months). The iliocaval confluence was stented in the same
procedure or the contralateral stenting was performed at a
later date.
All limbs were classified using the CEAP classification
according to the reporting standards of the International
Society for Cardiovascular Surgery (ISCVS)/Society for
Vascular Surgery (SVS)8,9 based on DUS study with stan-
dardized compression.10,11 The patients were routinely
surveyed at 3, 6, and 12 months after stenting and then
annually with transfemoral or ascending venography and
DUS imaging to assess patency. Patency was defined as
visible flow throughout the entire bilateral stent system.
Reintervention was performed because of residual/
recurrent symptoms or because of stent malfunction, in-
cluding stent occlusion, presence of 50% in-stent steno-
sis, collaterals, and inflow or outflow abnormalities found
on routine surveillance in the stented IVC or one or both of
the stented iliac limbs, or both. Intervention in most limbs
was performed based on venography, which was obtained
when DUS imaging suggested stent malfunction. The type
and frequency of reinterventions were noted.
Although the main end point of this study was not
clinical outcome, some perioperative symptomatic out-
comes are given. The study end point of legs with stasis
ulceration was complete epithelialization. The degree of
pain was evaluated perioperatively using a visual analog
scale (VAS) from 0 to 10, where 10 indicates the most
severe pain.12 Swelling was assessed as grade 0 (absent),
grade 1 (pitting, not obvious), grade 2 (visible ankle
edema), and grade 3 (massive, encompassing the entire leg)
according to reporting standards.
Technique. The diagnosis of obstruction, indications
for iliofemoral stenting, technical details of unilateral en-
dovenous stenting, and perioperative anticoagulation treat-
ment have been described previously.7,13-17
DUS-guided venous access of the common femoral,
femoral, or popliteal vein bilaterally was performed under
general anesthesia in all patients. Both nonocclusive and
occlusive obstructions were always dilated before stent
placement. Only braided stainless steel Wallstents (Boston
Scientific, Natick, Mass) were used. Stents treating com-mon iliac vein obstruction adjacent to the iliocaval conflu-
ence, whether they were unilateral or bilateral lesions, were
frequently placed into the IVC (minimally 3 cm or further)
to prevent caudad migration. Bilateral caudad extension
was performed as necessary to cover the entire obstructive
lesion and to ensure an adequate inflow. Principally, three
different techniques were used in this study:
1. Double-barrel technique (group DB; n  39). After
bilateral femoral vein access, bilateral guidewires were
placed into the IVC, and a bilateral balloon venoplasty
was performed with a “kissing balloon” technique (the
same as used at the aortic bifurcation). Two braided
stainless steel stents (9 cm long and 14 to 16 mm wide)
were then placed and released concurrently starting at
the same level in the IVC in a double-barrel fashion
crossing the confluence into both iliac veins (Fig 1).
Balloon dilation was repeated after the placement of the
stents. This technique leaves an uninterrupted outflow
from both iliac veins.
2. Inverted Y fenestration (group iY; n  38). This tech-
nique is more complicated and requires a fenestration. A
stent was placed that covers the iliocaval confluence
unilaterally. Through a contralateral venous access, a
guidewire was pushed through the mesh of the side of
the braided stent. The penetration of the stent and
placement of the guidewire through the side of the
initially inserted stent may sometimes be difficult. Place-
ment of a supporting sheath up to the side of the stent
may aid passage. It is occasionally easier to pass a guide-
wire through the stented iliac vein to the contralateral
iliac vein, catch it with a loop from that side, and pull it
out through the sheath, creating a “body-floss” situa-
tion. This will stabilize the guidewire and sometimes
makes the passage of a balloon easier through the side of
the stent.
Penetration of the stent may be facilitated by the
use of a transjugular intrahepatic portosystemic shunt
(TIPS) needle (Cook, Bloomington, Ind), which was
applied in 10 patients in this study (Fig 2).18,19A low-
profile balloon with tapered tip was then placed over the
guidewire crossing the stent braiding and inflated, cre-
ating a small opening (fenestra) in the side of the stent.
If the balloon cannot be passed, the dilator in the TIPS
set may be pushed through the braiding to separate
the steel wires. After sequential balloon dilation with
larger, high-pressure Atlas balloons (14-16 mm diam-
eter; Bard Peripheral Vascular, Inc, Tempe, Ariz), the
braiding of the stent was deformed and a larger
opening was created (Fig 3, A). The stainless steel
wires of the braided stent do not appear to fracture
during this maneuver, and the adjacent part of the
stent seems to be unaffected.
A stent at least the diameter of the contralateral stent
was then inserted over the wire through the fenestration
across the outflow of the previously inserted stent in an
inverted Y configuration. A generous overlap was nec-
essary to prevent foreshortening and retraction of the
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C and D). The initially stented iliac vein was crossed by
the second stent. Fenestration was not routinely per-
formed of the “jailing” stent unless the flow was consid-
ered impeded (Fig 4).
In the presence of bilateral iliac venous occlusion,
guidewire recanalization, balloon dilation, and stenting
were performed on one side. The contralateral side was
then recanalized and access through the side of the
previously placed stent was achieved using the tech-
niques described above.
3. Apposition (group A; n  38). This technique was the
Fig 1. Images of stenting of the iliocaval confluence by
balloons, same-sized stents are inserted and simultaneou
distally into each common iliac vein. B, The stents are d
expanded with no kinking at the iliocaval junctions. D, T
adjoining stents just above the confluence in the IVC. T
IVUS catheter.only one used before the year 2000, before the previ-ously described techniques were applied. Presently, this
technique is used only selectively in the event a penetra-
tion of the side of the stent fails during inverted Y
fenestration. A stent overriding the iliocaval confluence
on one side across the outflow of the contralateral iliac
vein had been placed previously. Through a contralat-
eral access, an additional stent was then placed as close
as possible to the side of the previously placed stent
(Fig 5). Owing to the design of the deployment device,
this placement left a short (1- to 2-cm) cephalad vein
segment between the stents uncovered. It should, there-
fore, be performed only when the cephalad, common
ouble-barrel technique. A After predilation by “kissing”
leased side-by-side in the inferior vena cava (IVC) and
simultaneously after insertion, and (C) are shown well
ntravascular ultrasound (IVUS) image shows clearly the
ack circle inside the stented vein represents the insertedthe d
sly re
ilated
his i
he bliliac vein is relatively healthy.
w (fen
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U) preoperatively, and intravenous unfractionated hep-
arin (3000 to 5000 U) was administered during the
procedure. Postoperatively, a foot compression device
was applied, subcutaneous dalteparin (2500 U) admin-
istered in the recovery room, and dalteparin (5000 U)
was repeated in the morning before discharge. Patients
Fig 2. A transjugular intrahepatic portosystemic shunt
mesh. A, A stiff Glidewire is inserted through the need
balloon that is inflated to separate the braided steel wires
larger high-pressure balloons are used to create a windo
Fig 3. A, The deformation creating a fenestra in the si
larger diameter is deployed well into the inferior vena c
dilation. C, Final result after balloon dilation after stent i
is “jailed.”whowere stented for nonthrombotic disease weremain-tained on low-dose oral aspirin (81 mg daily) alone.
Patients stented for postthrombotic obstruction who
were already receiving warfarin preoperatively, those
with prior recurrent deep vein thrombosis, or those
known or preoperatively discovered to have thrombo-
philia, were anticoagulated with warfarin postopera-
tively, otherwise they were maintained on low-dose
le, supported by a sheath, is pushed through the stent
The needle is replaced by a low-profile small-diameter
low insertion of a larger balloon. C and D, Sequentially
estra).
the stent is clearly visualized. B, A stent of the same or
nd distally to avoid slipping out of the fenestration on
on shows the outflow of the contralateral iliac stent limbneed
le. B,
to alde of
ava a
nsertiaspirin. Patients with a recanalization procedure and
veins
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dalteparin for 7 to 14 days and then converted to
full-dose warfarin.
Statistical analysis. Categoric variables were ana-
lyzed by 2 test. Primary, assisted primary (patency after
preemptive intervention), and secondary patency (pa-
tency after intervention for occlusion) rates, as defined
by the reporting standards of the SVS/ISCVS,8 were
calculated using survival analysis with the Kaplan-Meier
method. Patency was assessed as flow in both limbs of the
stent system and in the stented IVC. The log-rank test was
Fig 4. A, Fenestration of a stent, which is placed ac
fenestration. Left, A balloon is placed through the side
unimpeded outflow. B, The unilateral dilation may som
stenosis. Left, It may be useful to perform balloon dila
(right) ensure an uninterrupted outflow from both iliacused to compare cumulative curves. Prism 3.0 software(GraphPad, San Diego, Calif) was used for analysis. Results
are reported using P values, with P  .05 considered
significant.
RESULTS
Stenting of the iliocaval confluence was performed in
115 patients (230 limbs). Median age was 54 years (range,
14-76 years), and female/male ratio was 2.8:1. The inter-
vention was performed for NIVL, so-called compression
lesions, in 141 limbs, and for chronic postthrombotic ob-
the outflow of one stented limb after an inverted Y
e stent and dilated, (right) creating a fenestra allowing
s infringe on the previous created window and result in
at the stent confluence by kissing balloon technique to
.ross
of th
etime
tionstruction in 89 limbs. Nonocclusive obstruction was
outfl
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were occluded and required recanalization before stenting.
The CEAP classification of the stented limbs is reported
in Table I. Limbs in class C2 were treated because of severe
pain and in C3 because of grade 3 venous edema. The C4-6
rate was significantly greater in group iY than in group DB
Fig 5. Stenting of the iliocaval confluence is shown usi
well into the inferior vena cava. B, A contralateral stent is
stent. The unsupported area is clearly shown, with good
Table I. CEAP classification of the limbs treated with
the three different techniques of stenting of the iliocaval
confluence
Variable
Group
Apposition DB iY
n  76 n  78 n  76
Clinical class, No.
C2 (varicose veins, pain 5) 5 7 2
C3 (venous edema) 40 46 37
C4 (dermatitis,
hyperpigmentation) 15 11 18
C5 (healed ulcer) 4 2 5
C6 (active ulcer) 12 12 14
Etiology, No.
Primary (NIVL) 45 56 40
Postthrombotic 31 22 36
Anatomy, No.
Deep 41 46 37
Deep/perforator 0 2 0
Deep/superficial 34 29 33
Deep/superficial/perforator 1 1 6
Pathology, No.
Obstruction 33 38 33
Obstruction/reflux 43 40 43
DB, Double-barrel; iY, inverted Y fenestration; NIVL, nonthrombotic iliac
vein lesion.(49% and 32%, respectively; P  .049), but not whencompared with group A (49% and 41%, respectively; P 
.415). Group DB had a significantly greater ratio of limbs
with NIVL than group iY (2.5/1 and 1.1/1, respectively,
P .022), but this was not significantly different compared
with group A (2.5/1 and 1.5/1, respectively, P  .141).
The frequency of limbs with reflux and of limbs with
involvement of the superficial system was the same in the
three groups.
Bilateral stenting was performed in 28 of 115 patients
(24%) at the same procedure. For obvious technical rea-
sons, this was more frequent in group DB than in groups A
and iY (54%, 9%, and 11%, respectively; P  .001). How-
ever, patients in groups A and iY were more often inten-
tionally staged than those in group DB (58%, 47%, and
18%, respectively; P  .001). The median time interval to
the contralateral stenting was 3 months (range, 1-9
months).
Significant symptoms subsequently developed in the
limbs of 40 patients with asymptomatic lesions of the
contralateral iliac vein. This was due to progress of the local
lesion and was not related to an acute thrombotic event
involving the previously inserted stent. It is uncertain
whether the jailing of the outflow after unilateral stenting
results in accelerated progression of lesions, but this is
unlikely because the rate of unintentional staging of con-
tralateral stenting is rare. The clinical condition required
stenting at a median of 11 months (range, 2-108 months)
after the first procedure.
The three techniques were applied with the same fre-
quency at the time of the nonintentional staging. The time
interval to the use of different types of confluence stenting
is shown in Fig 6. The more delayed the second stenting
e apposition technique. A, A unilateral stent is inserted
d as close as possible to the side of the previously inserted
ow through the side of the initially placed stent.ng th
placewas, the more frequently inverted Y fenestration was used.
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months) in 107 patients (93%). During this time, occlusion
of a stented area occurred 3 months to 7 years after primary
stenting in four patients in group iY treated for postthrom-
botic obstruction. The stent system occluded bilaterally in
one patient, and patency could not be restored. This patient
had undergone an initially successful recanalization and
stenting of a postthrombotic occlusion of her infrarenal
IVC and both iliac veins. Another physician discontinued
her anticoagulation therapy because of symptoms sugges-
tive of gastrointestinal bleeding, and it was never restarted.
Three patients had unilateral iliac vein stent occlusion,
which did not affect the stented IVC and contralateral iliac
vein, and two were successfully reopened by pharmacome-
chanical thrombolysis. In addition, 29 reinterventions were
performed of nonobstructive stent malfunctions (Table II).
Limbs in group DB had significantly lower frequency of
reinterventions than limbs in groups A and iY (8%, 32%,
and 37%, respectively; P  .01).
Caudad de novo stenosis, which required distal exten-
sion of the stent system, was observed in the limbs of all
groups. The most common procedure in limbs treated with
the apposition technique was proximal extension covering
the area between the previously inserted stents that were
not covered at the primary procedure (8 limbs). In five
limbs, the extension necessitated a fenestration and an
inverted Y conversion was performed. In three limbs, it was
possible to insert a stent and create a double-barrel config-
uration. The most common intervention in limbs with the
inverted Y fenestration was balloon dilation and distal
extension. In two patients, fenestration of the jailed stent
limb was performed to improve the venous outflow.
The overall primary, assisted primary, and secondary
Fig 6. The type of stent technique used at the iliocaval confluence
and the time interval between the initial and second procedure in
patients with intentionally staged procedures (Staged) and in those
who underwent a second stenting owing to development of symp-
toms in the contralateral lower limb (Symptoms). iY, inverted Y
fenestration.patency rates for the bilateral stent system at 4 years were61%, 92%, and 98%, respectively (Fig 7). The patients in
group Awhowere converted to double-barrel or inverted Y
configurations were censored at the time of conversion.
The distribution of occluded stent system and frequency of
reinterventions are reflected in the primary and secondary
patency rates for groups A, DB, and iY at 4 years of 77% and
100%, 73% and 100%, and 41% and 90%, respectively
(Fig 8). There was no significant difference between groups
A and DB, but primary and secondary patency rates were
significantly lower in group iY than in the other groups
(log-rank test; P  .001 and P  .007, respectively).
The effect of severity (occlusion vs nonocclusive ob-
struction), etiology of obstruction (thrombotic vs non-
thrombotic), and staging of the procedure was assessed.
The patients with occlusive lesion were all in group iY.
When patients treated for occlusive lesions were removed,
the primary and secondary patency rates increased to 53%
and 100%, respectively. The secondary patency was then
Table II. Reinterventions performed because of
nonobstructive stent system malfunction in 27 patients
during the follow-up period
Reintervention
Group
Apposition DB iY
(n  38) (n  39) (n  38)
Proximal stent extension only,
No. 3 0 1
 distal stent extension 4 0 1
 dilation 0 1 2
 dilation and distal stent
extension 1 0 0
Distal stent extension only, No. 1 2 3
Dilation only, No. 2 0 5
 stenting of distal skip area 1 0 0
Fenestration of jailed limb, No. N/A N/A 2
All, No. 12 3 14
DB, Double-barrel; iY, inverted Y fenestration; N/A, not applicable.
Fig 7. Cumulative primary, assisted primary, and secondary pa-
tency rates are shown for 107 patients with a bilateral stent system.
The lower numbers represent limbs at risk at each time interval (all
standard of means 10%).the same in all treatment groups, but the primary patency
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other groups.
In an effort to make these techniques more compara-
ble, a further analysis was performed only in patients with
nonocclusive obstruction and their patency rates were com-
pared. Primary patency rates for the methods were com-
pared by multiple logistic regressions while adjusting for
etiology and whether the procedure was staged. Assisted
primary and secondary patency rates were not analyzed
because only one occluded patient achieved either of these
types of patency. Preliminary analyses suggested that inter-
action terms were insignificant (P  .25 in each case), and
etiology and staging also did not contribute to the model
(P  .4467 and P  .5454, respectively). The final logistic
regression model suggests primary patency rates are signif-
icantly different between DB and iY (odds ratio [OR],
4.35; 95% confidence interval [CI], 1.03-18.45; P 
.0460) and between DB and A (OR, 4.94; 95% CI, 1.24-
19.76; P  .0238), and not significant between A and iY
(OR, 0.88; 95% CI, 0.29-2.63; P .8196). This indicated
that group DB had higher primary patency than groups A
and iY, regardless of etiology or staging of the procedure.
The clinical outcome is not dependent on the type of
stenting technique at the confluence as long as the stent
remains widely patent, but reflects associated venous pa-
thology. The clinical results are summarized in groups DB,
A, and iY by complete relief of pain (85%, 86%, and 71%)
and swelling (40%, 46%, and 42%), as well as by the ulcer
healing rate (62%, 50%, and 43%) at the last follow-up. The
clinical outcome is similar in the three groups, with some
deterioration in group iY that probably reflects the increas-
Fig 8. Cumulative primary and secondary patency rates of bilat-
eral stent systems in groups undergoing apposition (A), double-
barrel (DB), and inverted Y fenestration (iY; see text for defini-
tion). The lower numbers represent bilateral stent system at risk at
each time interval (standard of means10% are shown by the error
bars).ing rate of limbs stented for postthrombotic disease withmore complex disease in the groups DB, A, and iY (28%,
41%, and 48%, respectively).
DISCUSSION
Clinical and stent outcomes after unilateral femoroilio-
caval stenting have previously been well described.2-5 The
inverted Y fenestration technique of stenting of the iliocaval
confluence has previously been mentioned, but without
technical details, in two previously published studies de-
scribing recanalization and stenting of the occluded
iliocaval venous outflow16 and obstruction of the IVC,14
respectively. The use of the double-barrel and apposition
techniques in the venous system has not previously been
described. Unlike the previous studies, this study describes
in detail the three techniques, compares the stent outcome
of different techniques, and gives recommendations how to
select the appropriate technique.
The results of this study suggest that chronic iliocaval
confluence obstruction in patients with bilateral symptoms
is best managed by bilateral stenting in a double-barrel
fashion when technically feasible. This technique had 100%
cumulative secondary patency rate at 4 years, the fewest
reinterventions, (8%), and no late stent occlusions. Double-
barrel placement is facilitated because the right and left
common iliac veins have the same diameter at the conflu-
ence, which allows the same sized stents to be placed. It is
important to oversize the stents to fill the lumen of the
IVC. The stents in the IVC create a figure of eight crosscut
area. Space outside the stent, which may be a concern at
arterial bifurcations, does not seem to create a problem at
the venous confluence.
However, the double-barrel technique can only be
used when the caval obstruction is limited to the distal
infrarenal IVC (3 to 5 cm) or when bilateral lesions of the
iliac veins adjacent to the confluence require stent exten-
sion into the IVC. The double-barrel stents should be
placed in the same setting. Delayed placement of the sec-
ond stent in the double-barrel configuration is discour-
aged, because it frequently compresses and deforms the
initially placed iliocaval stent and compromises the outflow
from that limb.
This technique is successful when the previously in-
serted stent only protrudes into the caval lumen and does
not reach the contralateral caval wall. This placement allows
easy passage of a stent from the contralateral side and a
double-barrel placement performed with elongation of the
previously placed stent by adding a cephalad stent. The
healthy IVC is usually very compliant and will accommo-
date two parallel stents. A nonocclusive postthrombotic
contracted IVC with dense wall fibrosis may recoil, despite
high-pressure dilation, and not allow double-barrel stent
placement.
Although the apposition technique had excellent sec-
ondary patency rate and no stent occlusions, reinterven-
tions were required at a high rate (32%). The unsupported
skip area between the stents inherent in this technique
often developed a restenosis and required additional stent
placement. This has been previously described to occur in
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ported in both the arterial and venous systems.20,21 The
proximal additional stents in fact converted the apposi-
tioned stents into an inverted Y fenestration or double-
barrel configuration.
The inverted Y fenestration technique is the only one of
the three described techniques that can be used when a
jailing contralateral iliocaval stent has previously been
placed or when bilateral iliac vein stenting is necessary in the
presence of extensive cephalad caval obstruction (5 cm).
It has the poorest stent-related outcome, with 11% late
occlusions and a 37% reintervention rate. This may be due
to the technique but is also related to the frequent presence
of postthrombotic disease in these patients (48%). Stent
patency rates and development of in-stent recurrent steno-
sis have previously been shown to be most significantly
related to the presence and severity (occlusive or nonocclu-
sive obstruction) of postthrombotic disease.5,15
An alternative to fenestration in cases with extensive
obstruction of the IVC has been described.17 A large-
diameter stent (at least 24 mm) is placed like a funnel in the
IVC, with its lower end at the confluence. Two iliocaval
stents are then inserted into the funnel proximally with the
double-barrel technique as described in this article. A sys-
tematic outcome evaluation of this technique has not been
published. It was not used in this study.
Techniques to treat bifurcation lesions using nitinol
stents have been described in detail by Sze et al.22 These
authors describe the alternative methods to cover bile duct
branching, arterial bifurcations, and confluences in the
venous system. It is well known that experience from
stenting in the arterial system is not necessarily transferable
to the venous circulation.16,23 There are several examples
of this observation. Unilateral iliocaval stenting across the
iliocaval confluence can be performed without using the
kissing-balloon technique. Jailing (stenting over branch
orifices) of arterial branches, such as the internal iliac artery,
coronary, or cerebral arteries, can be deleterious. With the
inverted Y fenestration technique, the iliac venous outflow
of one limb is “jailed” by the second stent, which is not
routinely fenestrated.
Our extensive previous experience with unilateral ilio-
caval stenting in which the contralateral outflow is routinely
jailed has minimal consequences.5 The NIVL caused by
iliac vein compression and intraluminal webs or postthrom-
botic obstruction is different from the arteriosclerotic oc-
clusive lesion. It requires and accepts high-pressure dilation
(up to 18 mmHg) with large balloon and stent sizes (16 to
20 mm diameter) without clinical rupture.
No study comparing the use of braided stainless steel
stent and a nitinol mesh stent at the iliocaval confluence has
been reported. We favor the use of the braided stainless
steel stent because of its greater radial force, stiffness,
diameter size (16 mm), and the theoretic advantage of
braiding that prevents crushing of the stent by allowing
longitudinal movement and less axial force underneath
focal pressure points, which are unique to the venous
system.1 Despite the greater radial strength and stiffness ofthese stents, the external compression is occasionally so
firm that additional balloon-expandable stents may have to
be inserted at pressure points or at angles with a tendency to
kink. It is not known what happens to the property of the
stents when they are fenestrated. The nitinol mesh stent
appears to fracture, whereas the braided stainless steel stent
appears to be deformed. The proximal focal compression
points at the confluence are closed to the site of fenestration
and may be less controlled owing to loss of radial force due
to local structural deformation at that site.
A major limitation of the comparison of the stenting
techniques in this study is that the techniques are not always
interchangeable, but are applied differently, dependent on
the extent, degree, and anatomic site of the obstructive
lesion, as well as the extent of previous unilateral stenting in
staged cases. The stent-related outcome may certainly be
affected by these factors and by whether the obstruction is
postthrombotic or the procedure is staged. Stratifying the
subsets of the different techniques to analyze these effects
results in an insufficient number of patients for adequate
statistical comparison for assisted primary and secondary
patency.
The comparison of stent outcome in patients with
similar type of nonocclusive lesions suggests that the fenes-
tration technique has a lower primary patency rate (requires
more frequently additional procedures) regardless of etiol-
ogy of the obstruction or staging of the procedure and that
occlusive postthrombotic obstruction may result in a lower
rate of secondary patency. Further studies are necessary to
elucidate these relationships.
CONCLUSION
Our preferred treatment of bilateral iliac nonthrom-
botic occlusive disease involving the iliocaval confluence is
to perform one-stage double-barrel stenting. In patients
with bilateral postthrombotic nonocclusive or occlusive
disease, the technique is largely dependent on the extent of
the disease in the IVC. With limited caudal involvement of
the IVC (5 cm) and a normal, compliant IVC above the
obstruction, insertion of stents in a double-barrel fashion is
usually possible. With extensive involvement of the IVC
(5 cm) or a cephalad fibrotic and noncompliant IVC,
doubling of the stent in the caval lumen is prohibited and
an inverted Y technique with fenestration is performed.
Appositional stents are only placed if fenestration fails.
Presently, there is no optimal solution to the treatment of
the iliocaval confluence. Development of modular stents
with side ostia that allow placement without covering out-
flow from the contralateral side is necessary.
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